Premature ovarian failure: Clinical evaluation of 32 cases;POF (Premature Ovarian Failure): Valutazione clinica di 32 casi

Minerva Ginecologica

Volumn 55, Issue 6, 2003, Pages 525-529

  Mainini, G ^a,b   Festa, B ^a   Messalli, E M ^a   Torella, M ^a   Ragucci, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

Ovarian failure, premature, diagnosis; Ovarian failure, premature, physiopathology; Ovarian failure, premature, therapy

Indexed keywords

ESTROGEN;

ADULT; AMENORRHEA; APOPTOSIS; ARTICLE; BONE METABOLISM; BONE MINERAL; BREAST DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COLPOSCOPY; CONTROLLED STUDY; ECHOGRAPHY; ECHOMAMMOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FEMALE INFERTILITY; HORMONE SUBSTITUTION; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOPOROSIS; OVULATION INDUCTION; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PREGNANCY; PREMATURE OVARIAN FAILURE; RISK FACTOR; UTERINE CERVIX DISEASE; UTERUS DISEASE;

ADULT; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE, PREMATURE; MIDDLE AGED; OVARY;

EID: 0842305890     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Laml T, Schulz-Lobmeyr I, Obruca A, Huber JC, Hartmann BW. Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000;14:292-302.
2. Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi EY, Rock JA, Rosenaks Z, editors. Reprodutive endocrinology, surgery, and technology. New York: Raven Press; 1995.p.1393-410.
3. Orshan SA, Furniss KK, Forst C, Santoro N. The lived experience of premature ovarian failure. J Obstet Gynecol Neonatal Nurs 2001;30:202-8.
4. Pal L, Santoro N. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002;1:413-23.
5. Conway GS, Kaltas G, Patel A, Davies M, Jacobs H. Characterization of idiopathic premature ovarian failure. Fertil Steril 1996;65:337.
6. Santoro N. Research on the mechanisms of premature ovarian failure. J Soc Gynecol Investig 2001;8(1 Suppl Proceedings):S10-2.
7. Parborell F, Pecci A, Gonzalez O, Vitale A, Tesone M. Effects of a gonadotropin-releasing hormone agonist on rat ovarian follicle apoptosis: regulation by epidermal growth factor and the expression of bcl-2-related genes. Biol Reprod 2002;67:481-6.
8. Testa G, Chiaffarino F, Vegetti W, Nicolosi A, Caliari I, Alagna F et al. Case-control study on risk factors for premature ovarian failure. Gynecol Obstet Invest 2001;51:40-3.
9. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and -B as markers. Mol Cell Endocrinol 2002;187:93-105.
10. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17:2096-100.
11. Chernyshov VP, Radysh TV, Gura IV, Tatarchuk TP, Khominskaya ZB. Immune disorders in women with premature ovarian failure in initial period. Am J Reprod Immunol 2001;46:220-5.
12. van Kasteren YM, von Blomberg M, Hoek A, de Koning C, Lambalk N, van Montfrans J et al. Incipient ovarian failure and premature ovarian failure show the same immunological profile. Am J Reprod Immunol 2000;43:359-66.
13. Yan G, Schoenfeld D, Penney C, Hurxthal K, Taylor AE, Faustman D. Identification of premature ovarian failure patients with underlying autoimmunity. J Womens Health Gend Based Med 2000;9:275-87.
14. Bione S, Toniolo D. X chromosome genes and premature ovarian failure. Semin Reprod Med 2000;18:51-7.
15. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002;8:729-33.
16. Machado-Ferreira MC, Costa-Lima MA, Boy RT, Esteves GS, Pimentel MM. Premature ovarian failure and FMR1 premutation co-segregation in a large Brazilian family. Int J Mol Med 2002;10:231-3.
17. Mallolas J, Duran M, Sanchez A, Jimenez D, Castellvi-Bel S, Rife M et al. Implications of the FMR1 gene in menopause: study of 147 Spanish women. Menopause 2001;8:106-10.
18. Marozzi A, Porta C, Vegetti W, Crosignani PG, Tibiletti MG, Dalpra L et al. Mutation analysis of the inhibin α gene in a cohort of Italian women affected by ovarian failure. Hum Reprod 2002;17:1741-5.
19. Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M et al. Genes and translocations involved in POF. Am J Med Genet 2002;111:328-33.
20. Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet 2000;97:189-94.
21. Zinn AR, Ross JL. Molecular analysis of genes on Xp controlling Turner syndrome and premature ovarian failure (POF). Semin Reprod Med 2001;19:141-6.
22. Surrey ES, Cedars MI. The effects of gonadotropin suppression on the induction of ovulation in premature ovarian failure. Fertil Steril 1989;52:36.
23. Van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic intervents to restore ovarian function and achieve pregnancy. Hum Reprod Update 1995;5:483-92.
24. Shantha S, Brooks-Gunn J, Locke RJ, Warren MP. Natural vaginal progesterone is associated with minimal psychological side effects: a preliminary study. J Womens Health Gend Based Med 2001;10:991-7.